After the US Research study, Pakistani authorities have banned the medicine companies and agencies over producing and selling of the medicines using the similar chemical agent.
The Drug Regulatory Authority of Pakistan (DRAP) has ordered all the pharmaceutical companies to stop manufacturing medicines using ‘Ranitidine’ and to recall all such products in the market. The substance is used to treat acidity and other stomach related issues.
The notification has come days after a Swiss pharma group Novartis recalled its popular product Zantac using this raw material.
